ASX:CSLBiotechs
CSL (ASX:CSL) Faces Pressure To Rebuild Confidence, Is It Still Trading At A Discount?
CSL (ASX:CSL) has put shareholder concerns front and centre after its board openly acknowledged frustration with the company’s weaker commercial and financial outcomes and pledged urgent investment in its core plasma operations to rebuild confidence.
Recent trading tells a mixed story. CSL’s share price has climbed around 51% over the past 90 days and about 5% over the last month, yet the 1 year total shareholder return is down about 9% and the 5 year total shareholder return has declined...

